Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway–mediated disorders

INTRODUCTION: Overactivation of the lectin pathway of complement plays a pathogenic role in a broad range of immune-mediated and inflammatory disorders; mannan-binding lectin-associated serine protease-2 (MASP-2) is the key effector enzyme of the lectin pathway. We developed a fully human monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudler, Thomas, Yaseen, Sadam, Cummings, W. Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663225/
https://www.ncbi.nlm.nih.gov/pubmed/38022610
http://dx.doi.org/10.3389/fimmu.2023.1297352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663225/
https://www.ncbi.nlm.nih.gov/pubmed/38022610
http://dx.doi.org/10.3389/fimmu.2023.1297352

Ejemplares similares